Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Theralase Technologies Inc. (TTX.F) Follow Add holdings 0.1090 +0.0020 +(1.87%) As of 8:04:38 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for TTX.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: TTX.F View More All News Press Releases SEC Filings Theralase Discovers New Mechanism of Action of Lead Drug Theralase(R) Closes Non-Brokered Private Placement TSX Penny Stocks: 3 Picks With Market Caps Under CA$300M Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments Ruvidar Demonstrates 7 Year Complete Response Ruvidar Effective in the Treatment of Herpes Theralase Technologies Full Year 2024 Earnings: Beats Expectations Theralase(R) Releases 2024 Annual Financial Statements Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson's Patients Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma Theralase(R) Demonstrates Effective Treatment of Herpes